Crinetics Pharmaceuticals, Inc.
CRNX
Jodie read · what matters now
Revenue reached $25.1 million from $1.0 million, while six-month operating cash use rose to $218.9 million.
The story is only the start. Jodie keeps watching the filing evidence, the companies connected to CRNX, and whether its market group begins moving.
Who this business touches
The relationships behind CRNX
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
Filing peers
Companies whose filings use similar operating language.
You can see the shape of the network here. Pro opens 1 more links, the original filing receipts, and alerts when connected names begin moving. See Pro →
What is moving around it
Live connections
CRNX is currently a Leader in the organic co-movement group Biopharmaceuticals and Care. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 1 filing-linked name are in the relationship map; none is currently confirmed as moving with the group.
Theme membership history
No durable theme membership has been observed for this name yet.